Isthmus Partners, LLC Forte Biosciences, Inc. Transaction History

Isthmus Partners, LLC

  • $815 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$2.96 - $36.67 $97 - $1,210
-33 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$31.5 - $42.5 $1,039 - $1,402
33 New
33 $1,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $397M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email